Location permission needed for a better experience.
EN
CV
MEMBERSHIPS
PUBLICATIONS
EDUCATION
  • 2017 Süleyman Demirel Üniversitesi Tıp Fakültesi Perinatoloji
  • 2016 Maryland Üniversitesi, Baltimore, Amerika Birleşik Devletleri / Fetal ekokardiyografi eğitimi
  • 2012 Etlik Zübeyde Hanım Kadın Hastalıkları Eğitim ve Araştırma Hastanesi Kadın Hastalıkları ve Doğum
  • 2007 Ankara Üniversitesi Tıp Fakültesi
  • 2001 Mersin Fen Lisesi
  • 1998 Adana Anadolu Lisesi
EXPERIENCE
  • 2020 Acıbadem Sağlık Grubu
  • 2019 - 2020 Özel Bursa Esentepe Hastanesi
  • 2017 - 2019 Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi
  • 2013 - 2014 Kars Devlet Hastanesi
  • 2012 - 2013 Afyon Zübeyde Hanım Doğumevi
MEMBERSHIPS
  • Türk Tabipler Birliği
  • Türk Jinekoloji ve Obstetrik Derneği
  • International Society of Ultrasound in Obstetric and Gynecologic (ISUOG)
  • Türk Maternal Fetal Tıp ve Perinatoloji Derneği
PUBLICATIONS
  • Prenatal diagnosis of Seckel syndrome at 21 weeks'' gestation and review of the literature. J Matern Fetal Neonatal Med. 2019 Jun;32(11):1905-1908. Akkurt MO, Pakay K, Akkurt I, Temur M, Korkmazer E.
  • The Utility of Feticide Procedure to Shorten the Induction-to-Abortion Interval in Medical Abortion Gynecol Obstet Invest. 2019;84(1):64-70. Akkurt MO, Akkurt I, Yavuz A, Yalcin SE, Coskun B, Sezik M.
  • Adnexal masses 5 cm in diameter or greater extirpated during cesarean operation. January 2019. The Journal of reproductive medicine. 64(1):33-37. Yalcin SE, Yalcin Y, Akkurt MO, Yavuz A, Sezik M.
  • Prenatal sonographic diagnosis of cephalopagus conjoined twins at 14 weeks of pregnancy. J Clin Ultrasound. 2018 Jul;46(6):408-411. Eris Yalcin S, Akkurt MO, Yavuz A, Yalcin Y, Sezik M.
  • İzole proteinüri saptanan gebe kadınların obstetrik sonuçlarının proteinüri şiddetine göre karşılaştırılması Perinatoloji Dergisi 2018; 26 (3): 107-111. Mehmet Özgür Akkurt, Bora Coşkun, Tuğberk Güçlü, Kaan Pakay, Engin Korkmazer.
  • Increased fetal epicardial fat thickness: A novel ultrasound marker for altered fetal metabolism in diabetic pregnancies J Clin Ultrasound. 2018 Jul;46(6):397-402. Akkurt MO, Turan OM, Crimmins S, Harman CR, Turan S.
  • Gestasyonel diabetes mellitus olgularında postpartum glukoz tolerans testi uygulamasının oranları ve uygulanmamasının nedenleri. Perinatoloji Dergisi 2018; 26 (2): 69 - 73. Engin Korkmazer, Emine Arslan, Özgür Akkurt, Muzaffer Temur, Tayfur Çift, Emin Üstünyurt.
  • Ense kalınlığı ölçümü: Kim doğru, kim yanlış? Perinatoloji Dergisi 2018; 26 (2): 64-68. Engin Korkmazer, Emine Arslan, Özgür Akkurt, Muzaffer Temur, Tayfur Çift.
  • Relationship between vascular cell adhesion molecule-1 and morbidly adherent placenta. J Gynecol Obstet Hum Reprod. 2018 Dec;47(10):549-553. Korkmazer E, Nizam R, Arslan E, Akkurt Ö.
  • The impact of concurrent pelvic organ prolapse reconstructive surgery on midurethral sling procedure outcome Ginekol Pol. 2018;89(4):189-94. Çoşkun B, Aksakal OS, Çoşkun B, Yurtçu E, Akkurt MÖ, Kafadar Ö, Doğanay M.
  • The role of anti- Mullerian hormone in predicting the response to clomiphene citrate in unexplained infertility. Taiwan J Obstet Gynecol. 2018 Oct;57(5):713-717. Coskun B, Dilbaz B, Karadag B, Coskun B, Tohma YA, Dur R, Akkurt MO.
  • Fetal manyetik rezonans görüntüleme endikasyonlarının incelenmesi. Perinatoloji Dergisi 2018; 26 (1): 18-24. Serenat Eriş Yalçın, Yakup Yalçın, Esra Nur Tola, And Yavuz, Mehmet Özgür Akkurt, Mekin Sezik, Mehmet Okan Özkaya.
  • Risk factors for relaparotomy after cesarean delivery and related maternal near-miss event due to bleeding. J Matern Fetal Neonatal Med. 2018 Oct 21:1-5. Akkurt MO, Coşkun B, Güçlü T, Çift T, Korkmazer E
  • Relationship between intercellular adhesion molecule-1 and morbidly adherent placenta. J Perinat Med. 2018 Dec 19;47(1):45-49. Korkmazer E, Nizam R, Arslan E, Akkurt Ö.
  • Prediction of maternal near-miss in placenta previa: a retrospective analysis from a tertiary center in Ankara, Turkey. J Matern Fetal Neonatal Med. 2018 Feb;31(3):370-375. Coskun B, Akkurt I, Dur R, Akkurt MO, Ergani SY, Turan OT, Coskun B.
  • Maternal serum ferritin as a clinical tool at 34-36 weeks'' gestation for distinguishing subgroups of fetal growth restriction. J Matern Fetal Neonatal Med. 2017 Feb;30(4):452-456. Akkurt MO, Akkurt I, Altay M, Coskun B, Erkaya S, Sezik M.
  • Prenatal olarak tanı konulan parsiyel monozomi 13q sendromu olgusu Cukurova Med J 2017;42(1):189-191. Serenat Eriş Yalçın, And Yavuz, Mehmet Özgür Akkurt, Mekin Sezik.
  • Yapısal olarak normal fetüslerde 24-28. gebelik haftaları arasında fetal epikardiyal yağ dokusu kalınlık ölçümü. Perinatoloji Dergisi 2017; 25(2): 59-63. And Yavuz, Mekin Sezik, Mehmet Özgür Akkurt, Serenat Eriş Yalçın, Gökhan Karakoç.
  • Prenatal diagnosis of rare co-occurrence of congenital diaphragmatic hernia and aortic coarctation. Cukurova Med J 2017;42(2):376-379. Mehmet Özgür Akkurt, And Yavuz, Serenat Eriş Yalçın, İltaç Akkurt, Mekin Sezik.
  • Prenatal diagnosis of inverted duplication deletion 8p syndrome mimicking trisomy 18. Am J Med Genet A. 2017 Mar;173(3):776-779. Akkurt MO, Higgs A, Turan OT, Turan OM, Turan S.
  • Maternal and perinatal outcomes in pregnancies with multiple sclerosis: a case-control study. J Perinat Med. 2017 May 24;45(4):455-460. Yalcin SE, Yalcin Y, Yavuz A, Akkurt MO, Sezik M.
  • The significance of reverse flow in ductus venosus between sixteen and twenty weeks'' gestation Turk J Obstet Gynecol. 2017 Mar;14(1):23-27. Karakoç G, Yavuz A, Eriş Yalçın S, Akkurt MÖ, Danışman N.
  • Comparison of bupivacaine and ropivacaine in combination with fentanyl used for walking epidural anesthesia in labor. Turk J Obstet Gynecol. 2017 Sep;14(3):170-175. Gündüz Ş, Eriş Yalçın S, Karakoç G, Akkurt MÖ, Yalçın Y, Yavuz A.
  • Can we consider cesarean myomectomy as a safe procedure without long-term outcome? J Matern Fetal Neonatal Med. 2017 Aug;30(15):1855-1860. Akkurt MO, Yavuz A, Eris Yalcin S, Akkurt I, Turan OT, Yalcin Y, Sezik M.
  • Reliability of posterior-left atrium space index measurements during 20-24 weeks of gestation in structurally normal fetuses J Perinat Med. 2016 Aug 1;44(6):613-7. Akkurt MO, Yavuz A, Akkurt I, Karakoc G, Sezik M.
  • A comparison of the effects of the most commonly used tocolytic agents on maternal and fetal blood flow. Turk J Obstet Gynecol. 2016 Jun;13(2):85-89. Güden M, Akkurt MÖ, Eriş Yalçın S, Coşkun B, Akkurt I, Yavuz A, Yirci B, Kandemir NÖ.
  • Risk factors of placenta previa: a population based study and the review of the literature. Med Science 2016; 5(4): 941-4. Cetin Aydin, Serenat Eris Yalcin, Yakup Yalcin, Dilek Uysal, Mehmet Ozgur Akkurt, And Yavuz, Halime Sen Selim, Esra Nur Tola.
  • An unusual complication of vesicoamniotic shunt: coiling of the shunt around lower extremity associated with dislodgement J Obstet Gynaecol. 2016;36(2):261-2. Akkurt MO, Yavuz A, Sezik M, Ozkaya MO.
  • Conventional 22- and 20-gauge needle for second trimester amniocentesis: A comparison of short term outcomes. Turk J Obstet Gynecol. 2016 Mar;13(1):27-30. Köse SA, Akkurt MÖ, Yavuz A, Eriş S, Tola EN, Özkaya MO, Sezik M.
  • Infant outcomes following midtrimester emergency cerclage in the presence of fully dilated cervix and prolapsing amniotic membranes into the vagina. J Matern Fetal Neonatal Med. 2016;29(15):2438-42. Ozgur Akkurt M, Yavuz A, Sezik M, Okan Ozkaya M.
  • Second Trimester Fetal and Maternal Epicardial Fat Thickness in Gestational Diabetic Pregnancies. Horm Metab Res. 2016 Sep;48(9):595-600. Yavuz A, Akkurt MO, Yalcin S, Karakoc G, Varol E, Sezik M.
  • Histopatolojik Olarak Ektopik Gebe Olduğu Kanıtlanan Hastalarda Serum Ca-125, Östradiol ve Progesteron Düzeyleri. 2015; 12(4): 140-143. And YAVUZ, Mehmet Özgür AKKURT, Gökhan KARAKOÇ, Mehmet Muammer DOĞAN, Yakup YALÇIN, Burak TATAR.
  • The evaluation of risk factors for failed response to conservative treatment in tubo-ovarian abscesses. J Turk Ger Gynecol Assoc. 2015 Nov 2;16(4):226-30. Akkurt MÖ, Yalçın SE, Akkurt İ, Tatar B, Yavuz A, Yalçın Y, Akgül MA, Kayıkçıoğlu F.
  • Tubal rupture in ectopic pregnancy: is it predictable? Minerva Ginecol. 2015 Feb;67(1):13-9. Karadeniz RS, Tasci Y, Altay M, Akkuş M, Akkurt O, Gelisen O.
  • Laparoscopic systemic devascularization of uterine cornu for cornual resection in interstitial pregnancy Turk J Obstet Gynecol. 2015 Sep;12(3):182-184. Yalçın Y, Tatar B, Erdemoğlu E, Akkurt MÖ, Yavuz A, Erdemoğlu. E
  • Utero-cutaneous Fistula after Multiple Abdominal Myomectomies: A Case Report. Balkan Med J. 2015 Oct;32(4):426-8. Akkurt MÖ, Yavuz A, Tatar B, Özkaya MO, Ekici Eİ.
  • Tubal Reanastomoz Sonrası Gebelik Sonuçları. 2015; 25(4): 227-230. And YAVUZ, Mehmet Özgür AKKURT, Yakup YALÇIN, Burak TATAR, Gökhan KARAKOÇ.
  • Prolapsing vaginal Mullerian cyst with cervical elongation mimicking cystocele. J Obstet Gynaecol. 2014 Feb;34(2):212-3. Dilbaz B, Şengül Ö, Dede S, Yerebasmaz N, Akkurt Ö.
  • Coexistence of endometriosis and uterine septum in patients with abortion or infertility J Obstet Gynaecol Res. 2011 Nov;37(11):1596-600. Demir B, Dilbaz B, Karadag B, Duraker R, Akkurt O, Kocak M, Goktolga U.

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP
How can we help you?